3rd Nano safety for success dialogue : Building Trust in Nanotechnologies. Brussels, 3-4 November 2009
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
Tag | 1 | 2 | Valor |
---|---|---|---|
LDR | 00000nam a22000004b 4500 | ||
001 | MAP20100002322 | ||
003 | MAP | ||
005 | 20100114174448.0 | ||
008 | 100114s2009 bel|||| ||| ||eng d | ||
040 | $aMAP$bspa | ||
084 | $a7 | ||
111 | 2 | $0MAPA20100002247$aNano Safety for Success Dialogue$d2009$cBruselas$n3º | |
245 | 1 | 0 | $a3rd Nano safety for success dialogue$b : Building Trust in Nanotechnologies. Brussels, 3-4 November 2009 |
260 | $aBrussels$bEuropean Commission$c2009 | ||
520 | $aNanomaterials on the market: what regulators need to know / Henrik Laursen -- Current information on the market presence of nanomaterials / Maila Puolamaa -- What about safety, is there a risk? Developments in 2009 / Wim de Jong -- Nano-Titanium Dioxide in Sunscreens / Gerald Renner -- NanoTiO2 in sunscreens/cosmetics: an important case study / Laura Degallaix -- Manufactured and Engineered Nanoparticles-TiO2: What can be learned from SCENIHR, and others / Thomas Jung -- Nano-particles in Paint / Craig A Barker -- Nano-particles in Paint / David Santillo -- Nanoparticles in paint - Comments / Rolf F. Hertel -- The safe use of carbon nanotubes in coating applications / A. J. Lecloux and F Luizi -- Carbon nanotubes in high-tech coatings: Comments on a case study / Henning Wriedt -- Comment from on presentation by A. Lecloux / Ken Donaldson -- Applied Nanotechnology for medical-devices / Rainer Hanselmann -- Applications of suspended Nano Silver : Case Study / Matthias Nüchter -- Nanosilver: a serious threat to public health / Rye Senjen -- Nanomaterials under REACH / Wim de Jong -- General Lessons from the Case Studies: Regulatory Issues / Diana Bowman -- Safety and Science Issues / Ken Dawson -- Nanotechnology and consumer information / Hilary Sutcliffe -- Review of business viewpoints - Lessons from four case studies / Thomas Epprecht | ||
650 | 1 | $0MAPA20080569709$aNanotecnología | |
650 | 1 | $0MAPA20080586546$aNuevas tecnologías | |
650 | 1 | $0MAPA20100001066$aNanomateriales | |
650 | 1 | $0MAPA20080601522$aEvaluación de riesgos | |
650 | 1 | $0MAPA20080550233$aCongresos | |
710 | 2 | $0MAPA20080440749$aComisión Europea | |
856 | $uhttp://ec.europa.eu/health/ph_risk/ev_20091103_en.htm#2 |